Table 4.
Incident non-fatal cardiovascular events in fatty liver disease participants without prevalent major adverse cardiovascular events at baseline
| NAFLD (n = 413) | MAFLD (n = 519) | |
|---|---|---|
| Myocardial infarction | 4.87 (3.57–6.63) | 5.11 (3.84–6.79) |
| Cerebrovascular accident | 2.75 (1.83–4.14) | 2.67 (1.81–3.96) |
| Congestive cardiac failure | 6.87 (5.28–8.92) | 5.21 (3.93–6.92) |
| Unstable angina | 2.30 (1.37–3.60) | 2.16 (1.40–3.35) |
Data presented as incidence rate per 1000 person-years (95% confidence interval)
NAFLD non-alcoholic fatty liver disease, MAFLD metabolic-(dysfunction) associated fatty liver disease